StonvexLoading…
StonvexStonvexStonvexCore line items from ENPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.47B | $1.33B | $2.29B | $2.33B |
Operating Income | $157.53M | $77.29M | $445.74M | $448.26M |
Net Income | $172.13M | $102.66M | $438.94M | $397.36M |
EPS (Diluted) | $1.29 | $0.75 | $3.08 | $2.77 |
Total Assets | $3.51B | $3.25B | $3.38B | $3.08B |
Total Liabilities | $2.42B | $2.42B | $2.40B | $2.26B |
Cash & Equivalents | $474.32M | $369.11M | $288.75M | $473.24M |
Free Cash Flow OCF − CapEx | $95.90M | $480.09M | $586.38M | $698.37M |
Shares Outstanding | 131.08M | 132.45M | 135.72M | 136.44M |